Dr. Ursula Schmidt-Erfurth discusses the use of AI-based OCT analysis for geographic atrophy at the FLORetina-ICOOR meeting. These tools help identify disease biomarkers and select patients for new complement inhibition treatments. They also allow for monitoring of treatment efficacy, providing crucial information for clinical management. Schmidt-Erfurth emphasizes the importance of this breakthrough in helping patients maintain healthy vision and prevent vision loss. She reports receiving research support from Apellis, Novartis, and Roche.
Source link
AI-based tools help monitor GA progression, treatment effects
